The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 07, 2009
Filed:
Apr. 11, 2003
Mónica Bequet Romero, Ciudad de La Habana, CU;
Boris Ernesto Acevedo Castro, Ciudad de La Habana, CU;
Jorge Victor Gavilondo Cowley, Ciudad de La Habana, CU;
Luis Enrique Fernández Molina, Ciudad de La Habana, CU;
Omar Lopez Ocejo, Ciudad de La Habana, CU;
Ricardo DE LA Caridad Silva Rodriguez, Ciudad de La Habana, CU;
Alexis Musachio Lasa, Mariel, CU;
Ernesto Galban Rodriguez, Ciudad de La Habana, CU;
Dania Marcia Vázquez Blomquist, Ciudad de La Habana, CU;
Mónica Bequet Romero, Ciudad de La Habana, CU;
Boris Ernesto Acevedo Castro, Ciudad de La Habana, CU;
Jorge Victor Gavilondo Cowley, Ciudad de La Habana, CU;
Luis Enrique Fernández Molina, Ciudad de La Habana, CU;
Omar Lopez Ocejo, Ciudad de La Habana, CU;
Ricardo de la Caridad Silva Rodriguez, Ciudad de La Habana, CU;
Alexis Musachio Lasa, Mariel, CU;
Ernesto Galban Rodriguez, Ciudad de La Habana, CU;
Dania Marcia Vázquez Blomquist, Ciudad de La Habana, CU;
Centro De Ingenieria Genetica Y Biotechnologia, Ciudad de La Habana, CU;
Abstract
Application of oligonucleotide and polypeptide sequences of molecules of the family of the vascular permeability factor (VPF), their receptors, and co-receptors, as well as their modifications, in the active immunotherapy of pathologic entities in which course is associated to the increase of angiogenesis. These procedures can be employed in the single or combined therapy for the treatment of cancer and its metastasis, acute and chronic inflammatory processes, infectious diseases, autoimmune diseases, diabetic and newborn retinopathies, organ transplant rejection, macular degeneration, neovascular glaucoma, hemangioma, and angiofibroma, among others.